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Plenary Session I: Stem Cell Biology
MOLECULAR BIOLOGY OF HEMATOPOffiSIS, I. Lemischka. 
Princeton University, Princeton, NJ, USA.
The hematopoietic stem cell has the ability to self-renew as well as 
the ability to commit to a number of differentiation pathways.
Much is known about the in vivo developmental behavior of the 
stem cell population through many years of mouse and human 
transplantation studies. In addition, the physical cellular 
phenotype of the stem cell has been described through numerous 
purification strategies. In spite of the large amount of available 
information, the exact molecular mechanisms which mediate the 
choice between self-renewal and commitment which occurs during 
stem cell division remain almost completely obscure. As a 
comprehensive approach to shed light on this issue we have: 1) 
embarked on a broad wide ranging effort to identify the gene 
expression patterns which exist in undifferentiated and highly 
purified mouse and human stem cells, 2) begun to analyze how 
these gene expression profiles are modified in response to 
cytokine-induced proliferation and differentiation, 3) developed an 
in vitro correlate of the hematopoietic microenvironment and have 
shown that this culture system can effectively support the 
establishment and long-term maintenance of the entire primitive 
stem/ progenitor cell hierarchy and 4) analyzed the panel of gene 
products specifically expressed in a stromal cell line which 
represents a candidate stem cell microenvironmental niche. To date 
our efforts have yielded approximately 1,000 cDNA sequences 
which are candidates for genes specifically expressed in 
stem/progenitor cells but not in more mature blood cell lineages.
In addition, over 500 sequences have been analyzed from the 
stromal cell line. Collectively these studies, while far from 
complete, have already yielded a considerable number of 
interesting molecules. The predicted amino acid sequences of 
these molecules strongly suggest important roles in the biology of 
the hematopoietic stem cell and microenvironment.
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INTERACTIONS BETWEEN PRIMITIVE HEMATOPOIETIC CELLS 
AND BONE MARROW STROMA. C.J. Eaves. I.P . Cashman*. L. 
Ponchio*. A-C. Eaves. Terry Fox Laboratory, British Columbia Cancer 
Agency, Vancouver, BC.
The longterm culture (LTC) system has proven a useful in vitro model of 
the bone marrow microenvironment because it reproduces many of the 
features of stromal cell-mediated regulation of primitive normal and 
leukemic cell behaviour in vivo, This includes effects on the viability, 
proliferation, self-renewal and differentiation of transplantable stem cells 
and LTC-IC, as well as interactions that can reversibly promote or arrest 
the cell cycle progression of normal, high proliferative potential colony- 
forming cells (HPP-CFC) of both erythroid and granulopoietic types. We 
have focussed on an analysis of the latter mechanism because it is one that 
CML HPP-CFC are able to evade both in vivo and in the LTC system. Its 
delineation might, therefore, help explain how the CML clone acquires a 
selective and deregulated growth advantage in vivo at the level of the CFC 
compartment. Our initial studies demonstrated an ability of normal LTC 
adherent layer cells to exert a strong localized anti-proliferative effect on 
normal (but not CML) HPP-CFC which could be manipulated in 
3 important ways: (1) by the addition of agents that activate endogenous 
production of various hematopoietic growth factors (or inhibitors), (2) by 
the addition of candidate direct-acting mediators, and (3) by the addition of 
antibodies or antagonists of endogenous mediators. From such studies we 
have identified 2 types of endogenous inhibitors that cooperate in forcing 
normal HPP-CFC to enter G„ in the LTC model. These are certain [} 
(-CC-) chemokines (ie, M IP-la  and MCP-1) which are active on normal 
but not CML HPP-CFC, and TGF-p, which is active on both normal and 
CML HPP-CFC. Other P (RANTES, MCP-2, MCP-3 and MIP-1JJ) and 
a  (-CXC-) chemokines (EL-8 and IP-10) were found to be inactive even on 
normal HPP-CFC. Interestingly, thus far MCP-1 is the only active 
chemokine found to contribute to the endogenous cycling control of 
normal HPP-CFC in LTC. We have also demonstrated a marked 
difference in the cycling activity of normal and CML LTC-IC in vivo. 
However, studies of normal LTC-IC cycling in the LTC system suggest 
that the inhibition of these more primitive cells, like their activation may 
involve different types or concentrations of factors than those that regulate 
HPP-CFC proliferation,
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ASSAYING NORMAL AND LEUKEMIC HUMAN STEM CELLS 
IN NOD/SC ID MICE. J. E. Dick Dept, of Genetics, Hospital for Sick 
Children and Dept, of Molecular and Medical Genetics, Univ. of 
Toronto, Toronto,
The only conclusive method to assay stem cells is to follow their ability 
to repopulate conditioned recipients making it difficult to study human 
stem cells. The development of systems to transplant human 
hematopoietic cells into immune-deficient mice lays the foundation for 
such an experimental repopulation assay for primitive human cells. 
Ceil purification and gene marking studies have shown that the 
repopulating cells, termed SCID-repopulating cells (SRC), are 
primitive and distinct from most of the progenitors that are detected 
using short and long-term in vitro culture assays. The SRC are
exclusively CD34+CD38’ and poorly infected with retrovirus vectors. 
This gene marking data is reminiscent of the human clinical trials 
establishing that the SRC assay is a good surrogate to develop 
improved transduction methods. Limiting dilution analysis has been 
used to establish a quantitative assay for SRC that can be used to 
precisely determine the effect of various cytokine cocktails on the 
iroliferation and differentiation of SRC during in vitro culture. We 
tave also used this system to identify a cell capable of initiating human 
AML by transplantation into NOD/SCID mice, termed the SCID 
Leukemia-Initiating Cell (SL-TC). In contrast to SCID recipients, these 
mice could be engrafted at limiting doses and with purified cells with 
AML samples with a myelomonocytic phenotype (AML-M4/M5). We
found that the SL-IC were always found in the CD34+CD38' fraction. 
The uniformity of the lcukemic stem cell phenotype in these diverse 
samples and the similarity to normal stem cells suggests that the target 
for leukemic transformation is a primitive normal stem for most cases 
of AML regardless of the phenotype of the leukemic blast cells. These 
data are consistent with the idea that the leukemic clone is organized as 
a hierarchy with SL-IC detecting a primitive cell.
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MECHANISMS OF STEM CELL MOBILIZATION IN MICE.
Fibbc^J.F.M . Pruiit*. L. Xatervecr*., C.G. Figdor. G. Opdcnakker*. R. 
W illemze. Dept, of Hematology, Leiden University Medical Center, Leiden, 
Dept, o f Tumor immunology, Nijmegen University, Nijmegen, The 
Netherlands and Rega Institute, Leuven, Belgium,
W hile mobilization is a property of most growth factors, relatively prolonged 
administration is required to induce mobilization. Previously, wc have 
demonstrated that interleukin-8 (IL-8) induces rapid (30 minutes) 
mobilization of hematopoietic progenitor cells (HPC) from the bone marrow 
(BM ) o f mice (Blood 85: 2269, 1995) and rhesus monkeys (Blood 87: 781, 
1996). In an attempt to explain the mechanisms underlying IL-S induced- 
mobilization we have studied the role o f p2 integrins and matrix 
metalloproteinasis (MMP). Balb-C mice were treated with in tra peritonea I 
injections of anti-LFA-1 antibody (H 154,163). IL-8-induccd mobilization of 
HPC was completely blocked by treatment with the anti-LFA-1 antibody, 
while mobilization induced by G-CSF or IL-1 was not. Addition of anti-LFA- 
1 antibody to colony cultures in semi solid media had no inhibitory cffcct. 
Transplantation o f blood derived mononuclear cells derived from IL-S 
mobilized animals pretreated with anti-LFA-1 or saline protected 95% and 
19% of lethally irradiated recipient mice respectively. These results indicate 
that anti-LFA-1 antibodies completely prevent the rapid mobilization'of 
colony forming cells and of cells exhibiting radioprotective capacity and 
indicate a major role for the p2 intcgrin LFA-1 in the mechanism of 
mobilization. To study a possible role for MMP in stem cell mobilization, 
circulating levels of gelatinase-B were determined by zymographic analysis in 
rhesus monkeys injected with IL-8. Enzyme levels increased up to 1000-fold 
concomitant with the increase in numbers of HPC. Rhesus monkeys were 
then injected with inhibitory monoclonal anti-gelatinasc-B antibodies (Rega 
3G12) prior to IL-8 injection, A dose on 1 mg/kg anti-gelatinase-B antibody, 
completely inhibited the IL-8-induced mobilization of progenitor cells. 
Zymographic analysis indicated die induction o f gelatinase-B protein. T hus,1 
IL-8 induced the rapid release of gelatinase-B with concurrent mobilization of 
HPC that could be prevented by blocking gelatinase-B enzyme activity. These 
data indicate the involvement o f gelatinase-B as a mediator of the IL-8 
induced mobilization of HPC.
